Optic disc and visual field progression in ocular hypertensive subjects: Detection rates, specificity, and agreement

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 7, 2006, Pages 2904-2910

  Strouthidis, Nicholas G ^a   Scott, Andrew ^a   Peter, Neena M ^a   Garway Heath, David F ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OPTIC DISK; PRIORITY JOURNAL; VISUAL FIELD; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; OPTIC NERVE DISEASE; PATHOLOGY; PROSPECTIVE STUDY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY; VISUAL DISORDER;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPTIC DISK; OPTIC NERVE DISEASES; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY; VISION DISORDERS; VISUAL FIELDS;

EID: 33746754282     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1584     Document Type: Article

References (45)

1. Higginbotham EJ, Gordon MO, Beiser JA, et al. The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals. Arch Ophthalmol. 2004;122:813-820.
2. Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279.
3. Tan JC, Garway-Heath DF, Hitchings RA. Variability across the optic nerve head in scanning laser tomography. Br J Ophthalmol. 2003;87:557-559.
4. Strouthidis NG, White ET, Ho TA, Hammond CJ, Garway-Heath DF. Factors affecting the test-retest variability of the Heidelberg Retina Tomograph and Heidelberg Retina Tomograph-II. Br J Ophthalmol. 2005;89:1427-1432.
5. Kamal DS, Viswanathan AC, Garway-Heath DF, Hitchings RA, Poinoosawmy D, Bunce C. Detection of optic disc change with the Heidelberg retina tomograph before confirmed visual field change in ocular hypertensives converting to early glaucoma. Br J Ophthalmol. 1999;83:290-294.
6. Kamal DS, Garway-Heath DF, Hitchings RA, Fitzke FW. Use of sequential Heidelberg retina tomograph images to identify changes at the optic disc in ocular hypertensive patients at risk of developing glaucoma. Br J Ophthalmol. 2000;84:993-998.
7. Johnson C, Cioffi G, Liebmann J, Sample P, Zangwill L, Weinreb R. The relationship between structural and functional alterations in glaucoma: a review. Semin Ophthalmol. 2000;15:221-233.
8. Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability. Ophthalmology. 1994;101:1445-1455.
9. Musch DC, Lichter PR, Guire KE, Standardi CL. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106:653-662.
10. Heijl A, Leske MC, Bengtsson B, Hussein M. Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol Scand. 2003;81:286-293.
11. Tan JC, Hitchings RA. Approach for identifying glaucomatous optic nerve progression by scanning laser tomography. Invest Ophthalmol Vis Sci. 2003;44:2621-2626.
12. Kamal D, Garway-Heath D, Ruben S, et al. Results of the betaxolol versus placebo treatment trial in ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2003;241:196-203.
13. McNaught AI, Crabb DP, Fitzke FW, Hitchings RA. Visual field progression: comparison of Humphrey Statpac2 and pointwise linear regression analysis. Graefes Arch Clin Exp Ophthalmol. 1996;234:411-418.
14. Viswanathan AC, Fitzke FW, Hitchings RA. Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2. Br J Ophthalmol. 1997;81:1037-1042.
15. Nouri-Mahdavi K, Caprioli J, Coleman AL, Hoffman D, Gaasterland D. Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods. Arch Ophthalmol. 2005;123:193-199.
16. Gardiner SK, Crabb DP. Examination of different point-wise linear regression methods for determining visual field progression. Invest Ophthalmol Vis Sci. 2002;43:1400-1407.
17. Strouthidis NG, White ET, Owen VM, Ho TA, Garway-Heath DF. Improving the repeatability of Heidelberg retina tomograph and Heidelberg retina tomograph II rim area measurements. Br J Ophthalmol. 2005;89:1433-1437.
18. Tan JC, Garway-Heath DF, Fitzke FW, Hitchings RA. Reasons for rim area variability in scanning laser tomography. Invest Ophthalmol Vis Sci. 2003;44:1126-1131.
19. Altman DG. Statistics and ethics in medical research. VI. Presentation of results. BMJ. 1980;281:1542-1544.
20. Johnson BM, Miao M, Sadun AA. Age-related decline of human optic nerve axon populations. Age. 1987;10:5-9.
21. Garway-Heath DF, Wollstein G, Hitchings RA. Aging changes of the optic nerve head in relation to open angle glaucoma. Br J Ophthalmol. 1997;81:840-845.
22. Garway-Heath DF, Poinoosawmy D, Fitzke FW, Hitchings RA. Mapping the visual field to the optic disc in normal tension glaucoma eyes. Ophthalmology. 2000;107:1809-1815.
23. McNaught AI, Crabb DP, Fitzke FW, Hitchings RA. Modelling series of visual fields to detect progression in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 1995;233:750-755.
24. Vesti E, Johnson CA, Chauhan BC. Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci. 2003;44:3873-3879.
25. Katz J, Gilbert D, Quigley HA, Sommer A. Estimating progression of visual field loss in glaucoma. Ophthalmology. 1997;104:1017-1025.
26. Spry PG, Bates AB, Johnson CA, Chauhan BC. Simulation of longitudinal threshold visual field data. Invest Ophthalmol Vis Sci. 2000;41:2192-2200.
27. Airaksinen PJ, Tuulonen A, Alanko HI. Rate and pattern of neuroretinal rim area decrease in ocular hypertension and glaucoma. Arch Ophthalmol. 1992;110:206-210.
28. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720; discussion 829-830.
29. Miglior S, Zeyen T, Pfeiffer N, Cunha-Vaz J, Torri V, Adamsons I. Results of the European Glaucoma Prevention Study. Ophthalmology. 2005;112:366-375.
30. Ervin JC, Lemij HG, Mills RP, Quigley HA, Thompson HW, Burgoyne CF. Clinician change detection viewing longitudinal stereophotographs compared to confocal scanning laser tomography in the LSU Experimental Glaucoma (LEG) Study. Ophthalmology. 2002;109:467-481.
31. Chauhan BC, Blanchard JW, Hamilton DC, LeBlanc RP. Technique for detecting serial topographic changes in the optic disc and peripapillary retina using scanning laser tomography. Invest Ophthalmol Vis Sci. 2000;41:775-782.
32. Artes PH, Chauhan BC. Longitudinal changes in the visual field and optic disc in glaucoma. Prog Retin Eye Res. 2005;24:333-354.
33. Fuchs E. Uer die lamina cribrosa. Albrecht von Graefes Arch Ophthalmol. 1916;91:435-485.
34. Hayreh SS, Pe'er J, Zimmerman MB. Morphologic changes in chronic high-pressure experimental glaucoma in rhesus monkeys. J Glaucoma. 1999;8:56-71.
35. Hernandez MR, Pena JD, Selvidge JA, Salvador-Silva M, Yang P. Hydrostatic pressure stimulates synthesis of elastin in cultured optic nerve head astrocytes. Glia. 2000;32:122-136.
36. Weber AJ, Harman CD. Structure-function relations of parasol cells in the normal and glaucomatous primate retina. Invest Ophthalmol Vis Sci. 2005;46:3197-3207.
37. Parisi V, Miglior S, Manni G, Centofani M, Bucci MG. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma. Ophthalmology. 2006;113:216-228.
38. Henson DB, Chaudry S, Artes PH, Faragher EB, Ansons A. Response variability in the visual field: comparison of optic neuritis, glaucoma, ocular hypertension, and normal eyes. Invest Ophthalmol Vis Sci. 2000;41:417-421.
39. Bengtsson B. Reliability of computerized perimetric threshold tests as assessed by reliability indices and threshold reproducibility in patients with suspect and manifest glaucoma. Acta Ophthalmol Scand. 2000;78:519-522.
40. Heijl A, Lindgren A, Lindgren G. Test-retest variability in glaucomatous visual fields. Am J Ophthalmol. 1989;108:130-135.
41. Chauhan BC, Tompkins JD, LeBlanc RP, McCormick TA. Characteristics of frequency-of-seeing curves in normal subjects, patients with suspected glaucoma, and patients with glaucoma. Invest Ophthalmol Vis Sci. 1993;34:3534-3540.
42. Sample PA, Boden C, Zhang Z, et al. Unsupervised machine learning with independent component analysis to identify areas of progression in glaucomatous visual fields. Invest Ophthalmol Vis Sci. 2005;46:3684-3692.
43. Tucker A, Vinciotti V, Liu X, Garway-Heath D. A spatio-temporal Bayesian network classifier for understanding visual field deterioration. Artif Intell Med. 2005;34:163-177.
44. Patterson AJ, Garway-Heath DF, Strouthidis NG, Crabb DP. A new statistical approach for quantifying change in series of retinal and optic nerve head topography images. Invest Ophthalmol Vis Sci. 2005;46:1659-1667.
45. Gardiner SK, Crabb DP, Fitzke FW, Hitchings RA. Reducing noise in suspected glaucomatous visual fields by using a new spatial filter. Vision Res. 2004;44:839-848.